Equity
€13,338 from €159,466 in 2015
Equity fell by 92% in 10 years.
Apotheek Devos
Lifetime
19 annual accounts with figures on one time axispeak €199,681 (2022)
€166,448▲ 7.6%
lowest -€59,198 (2016)
-€24,132▲ €12,369
peak €159,466 (2015)
€13,338▼ 64.4%
€1.0m▲ 0.6%
peak 1.6 FTE (2025)
1.6 FTE▲ 23.1%
Board3 names since 2021
2 directors and 1 other
Owners
99%
Documentsfilings and deeds
29-06-202632 days before the deadline
2025abbreviated format
Loss of €24,132Staff from 1.3 FTE to 1.6 FTEEquity from €37,470 to €13,338
Key points
from the 2025 annual accountsLosses
-€92,629 in three years
Every financial year from 2023 to 2025 closed with a loss. 2024 was the heaviest.
Debts
€1.0m 99% of the balance sheet
Financial debts 59%Suppliers 7%Taxes and wages 1%Other 33%
Of this, €532,904 falls due within a year.
Staff
2 employees on 31-12-2025
In 2025, 4 people joined and 4 left.
Filings
19 annual accounts since 2007
The 2017 accounts came 31 days late. The other nine of the last ten were filed on time.
Position in the sector
1.3%
Lower solvency than 87% of companies in retail trade. Sector median 36.9% · 13,234 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,037 companies had the same profile as Apotheek Devos has now. Each dot stands for 3 companies, two years later.
93.8%
were still trading
2.9%
stopped another way
2.9%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,037 companies, not a prediction for Apotheek Devos. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director,
Director
- 99%score equity €618,231 (2025) · 30-06-2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0888712416
3 managers resigning, 2 directors reappointed
Resignations: , and · Reappointments: (director) and (director) · Permanent representative: · General meeting of 04-08-2023 · Gazette deed
Registered office moved within Buizingen
New registered office: Alsembergsesteenweg 91 te 1501 Buizingen · Previous registered office: Pallieterweidestraat 16, 1501 Buizingen · Board meeting of 19-02-2017 · Gazette deed
Incorporation
published on 20-04-2007 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Apotheek Devos Halle | €1.0m | €166,448 | 1.3% | 1.6 |
| PHARMACIE DU LOTHIER Genappe | €1.1m | €165,870 | 46.3% | 1.5 |
| APOTHEEK VAN ACOLEYEN Meise | €1.2m | €202,826 | 41.9% | 1.8 |
| PHARMACIE BENEDICTE GUISSET BEAUMONT Beaumont | €0.9m | €198,023 | 28.3% | 1.6 |
| PHARMACIE PHARMAVIE HARCHIES Bernissart | €1.0m | €172,555 | 58.2% | 1.6 |
| APOTHEEK I. VAN PELT Beveren-Kruibeke-Zwijndrecht | €0.8m | €182,356 | 59.3% | 1.4 |
| APOTHEEK BREENDONKFARMA Puurs-Sint-Amands | €1.1m | €227,351 | 64.5% | 1.6 |
These companies have the same main activity as Apotheek Devos: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €813,000 and €1.2m, founded between 2000 and 2008.
Official details
Source: KBO- Status
- Active since 12-04-2007Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.162.421.3941501 Halle, since 12-04-2007
- Financial year end
- 31 December
- Peppol
- Reachable since 07-12-2025
Annual accounts 2025
- ≈ €780,000estimated
- €1.0m▼ 1.8%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on Apotheek Devos
Apotheek Devos files the abbreviated format. That format states no turnover. The gross margin fell from €173,547 in 2007 to €166,448 in 2025.
The balance sheet grew most in 2016 through fixed assets.
holds 99% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Apotheek Devos
- What is the company number of Apotheek Devos?
- The company number of Apotheek Devos is 0888.712.416. The VAT number is the same number with BE in front: BE 0888.712.416.
- Where is Apotheek Devos based?
- The registered office is at Alsembergsesteenweg 91, 1501 Halle.Company details
- What does Apotheek Devos do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Devos?
- Apotheek Devos is a private limited company (BV).
- When was Apotheek Devos founded?
- Apotheek Devos was founded on 12-04-2007.
- Is Apotheek Devos still active?
- Yes, Apotheek Devos is an active enterprise in the KBO register.
- How many employees does Apotheek Devos have?
- Apotheek Devos had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Apotheek Devos fall under?
- In its 2025 annual accounts, Apotheek Devos states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Apotheek Devos?
- The turnover in financial year 2025 is ≈ €780,000. This figure is estimated from the gross margin of €166,448 and 51 comparable companies (NACE 477). It probably lies between €520,000 and €1.5m.
- Is Apotheek Devos profitable?
- In financial year 2025, Apotheek Devos made a loss of €24,132.
- Where can I find the annual accounts of Apotheek Devos?
- Apotheek Devos filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Devos due?
- Apotheek Devos must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.